• FirefoxInstall the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    More On AEZS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Aeterna Zentaris Inc. (AEZS)

    -NasdaqCM
    0.62 Down 0.01(1.51%) Feb 26, 3:59PM EST
    Add to Portfolio
    Prev Close:0.63
    Open:0.62
    Bid:0.40 x 400
    Ask:N/A
    1y Target Est:1.34
    Beta:2.34
    Next Earnings Date:N/A
    Day's Range:0.61 - 0.64
    52wk Range:0.48 - 1.54
    Volume:424,857
    Avg Vol (3m):708,988
    Market Cap:40.47M
    P/E (ttm):N/A
    EPS (ttm):-0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEZS

    Comparison

    Symbol% ChgMkt Cap
    AEZSDown 1.51%40.47M
    CELGUp 0.20%98.75B
    ENMD 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.49
    Quarterly EPS Est (Dec-14) :-0.10
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback